Cyclo Therapeutics Inc - Ordinary Shares - Class A
CYTH
Get informed when a big investor buys or sells
+ FollowMarket Cap$23.59M
Close$
Share Statistics
| Market cap | $23.59 Million |
|---|---|
| Enterprise Value | $22.69 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.23 |
| Beta | -0.57 |
| Outstanding Shares | 28,729,641 |
Return
| Return on Equity | 184.06% |
|---|---|
| Return on Assets | -472.02% |
| Return on Invested Capital | 183.25% |
Valuation & Multiples
| P/E Ratio | -0.59 |
|---|---|
| PEG | -0.69 |
| Price to Sales | - |
| Price to Book Ratio | -0.72 |
| Enterprise Value to Revenue | 26.06 |
| Enterprise Value to EBIT | -0.92 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cyclo Therapeutics Inc
8 employeesCyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from disease. The Company’s Trappsol® Cyclo™, an orphan...